10.10.2022 | Kuopio Chamber of Commerce
Marginum joins Kuopio Chamber of Commerce and the Finnish Startup Community after winning Tahko Ski Lift Pitch 2022.
4.10.2022 | University of Eastern Finland
Marginum has been nominated by University of Eastern Finland (UEF) to participate at Stage Two competition in Berlin.
13.9.2022 | Kuopio Health
Marginum joined Kuopio Health to further connect with research institutions and other member companies in the medical technology industry.
6.9.2022 | Tekniikka&Talous
Cancerous tissue could be completely removed in the first operation. In this story, we’ll tell you what Marginum’s device is all about.
14.6.2022 | Business Kuopio
Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours.
27.4.2022 | Finnish Medical Journal
Precision techniques such as Marginum’s aspirate tissue monitoring enable unprecedently efficient identification of cancer tissue and the best possible treatment.
25.4.2022 | Mediuutiset
Contemporary techniques in glioma surgery are limited by their complexity, subjectivity and randomness, resulting in reoperations and suboptimal care.
11.4.2022 | Savon Sanomat
Marginum was selected as the winner of Tahko Ski Lift Pitch and awarded with the chance to be featured on the Nasdaq billboard in New York's Times Square.
7.2.2022 | Finnish Venture Capital Association
Finnish start-up Marginum raises first venture capital funding from Nostetta Ventures for the commercialisation of smart tissue monitor.
5.2.2022 | Savon Sanomat
CEO Lehtonen shared his thoughts on the development of Marginum’s technology and on how the innovation was borne from multidisciplinary research.